Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

ABT - ABBOTT LABORATORIES


134.95
-0.290   -0.215%

Share volume: 5,918,439
Last Updated: Mon 24 Feb 2025 10:00:00 PM CET
Surgical and Medical Instrument Manufacturing : -0.21%

PREVIOUS CLOSE
CHG
CHG%

$135.24
0.03
0.00%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
44%
Profitability 45%
Dept financing 24%
Liquidity 21%
Performance 53%
Company vs Stock growth
vs
Performance
5 Days
1.34%
1 Month
4.26%
3 Months
14.24%
6 Months
19.74%
1 Year
13.70%
2 Year
35.26%
Key data
Stock price
$134.95
P/E Ratio 
14.56
DAY RANGE
$134.30 - $136.59
EPS 
$3.30
52 WEEK RANGE
$99.71 - $136.59
52 WEEK CHANGE
$13.02
MARKET CAP 
195.160 B
YIELD 
1.96%
SHARES OUTSTANDING 
1.740 B
DIVIDEND
$0.55
EX-DIVIDEND DATE
07/15/2024
NEXT EARNINGS DATE
N/A
BETA 
0.26
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$5,409,744
AVERAGE 30 VOLUME 
$6,481,470
Company detail
CEO: Robert B. Ford
Region: US
Website: abbott.com
Employees: 115,000
IPO year: 1983
Issue type: Common Stock
Market: NYSE
Industry: Surgical and Medical Instrument Manufacturing
Sector: Manufacturing

Abbott Laboratories discovers, develops, manufactures, and sells health care products. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases.

Recent news